Type I cardiorenal syndrome in patients with acutely decompensated heart failure: the importance of new renal biomarkers.


Atici A., Emet S., Cakmak R., YURUYEN G., Alibeyoglu A., AKARSU M., ...Daha Fazla

European review for medical and pharmacological sciences, cilt.22, sa.11, ss.3534-3543, 2018 (SCI-Expanded) identifier identifier identifier

Özet

OBJECTIVE: Type 1 cardiorenal syndrome (CRS) is an acute renal failure in patients with acute decompensated heart failure with an incidence of 24% to 45%. The aim of our study was to investigate the significance of new renal biomarkers to predict type 1 CRS.